Efficacy of Intensified Transcranial Direct Current Stimulation in

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Clinical Trial Summary

This is a randomized, double-blind, parallel-group, sham-controlled trial that aims to investigate the effectiveness of transcranial direct current stimulation (TDCS) on improving symptoms, quality of life, depression, and cognitive functions in 39 patients with obsessive-compulsive disorder (OCD) that are randomized in 3 experimental groups.

See also
	Status	Clinical Trial	Phase
	Completed	`NCT04221841` - Executive Functions and Reinforcement Sensitivity in Women With Obsessive Compulsive Symptoms
	Recruiting	`NCT05292807` - Imagery Rescripting and Imaginal Exposure for Anxiety Symptoms	N/A

NCT number	NCT05501132
Study type	Interventional
Source	The National Brain Mapping Laboratory (NBML)
Contact
Status	Completed
Phase	Phase 1
Start date	August 1, 2020
Completion date	February 25, 2022

Efficacy of Intensified Transcranial Direct Current Stimulation in Obsessive-compulsive Disorder

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms